EB-1B Outstanding Researcher Green Card for Houston Scientists
The EB-1B outstanding researcher category requires a permanent job offer from a qualifying U.S. research institution — making it employer-dependent, unlike EB-1A. In Houston, the dominant EB-1B sponsors are the Texas Medical Center institutions — MD Anderson Cancer Center, Baylor College of Medicine, Houston Methodist Research Institute, UTHealth Houston, and Texas Children's Hospital — together with Rice University, the University of Houston, and qualifying research employers in the energy sector and at NASA JSC contractor organizations.
Outstanding researchers across the Texas Medical Center.
EB-1B in Houston originates primarily from the Texas Medical Center institutions. The TMC is the world's largest medical complex and home to more than 60 institutions — when any of them offers a permanent faculty or research appointment, the institution can sponsor EB-1B provided the researcher's record demonstrates they are outstanding in the field. MD Anderson's immigration office is one of the most experienced in the country for outstanding-researcher petitions; the institution sponsors EB-1B at scale for its cancer researchers, clinician-scientists, and laboratory faculty. Baylor College of Medicine and Houston Methodist Research Institute have established immigration processes for permanent faculty at the assistant professor level and above.
Beyond the TMC, Rice University and the University of Houston sponsor EB-1B for ladder-rank faculty. Energy companies with qualifying research departments — those employing at least three full-time researchers with documented accomplishments in the field — can sponsor EB-1B under the private-employer route. NASA JSC researchers employed through universities or contractor organizations may also have access to EB-1B sponsorship through those entities, though federal civil service employees are not eligible for employer-sponsored EB-1B from NASA directly.
MD Anderson Cancer Center
Sponsors EB-1B at scale for permanent faculty appointments (Assistant Professor and above) and comparable research-track positions in all oncology disciplines; the institution's immigration office is highly experienced; MD Anderson's #1 US News ranking and NCI-designation are powerful anchors for the distinguished-organization requirement and the outstanding-in-the-field standard.
Baylor College of Medicine
Sponsors EB-1B for permanent faculty in genetics, neuroscience, cardiovascular medicine, pediatrics, and basic sciences; the Office for International Affairs coordinates filings with outside counsel; publication records in Nature Genetics, Cell, and NEJM are common scholarly-articles anchors; Baylor's HHMI and Nobel Prize heritage supports the distinguished-organization argument.
Houston Methodist Research Institute
Sponsors EB-1B for permanent research faculty affiliated with Weill Cornell Medicine; strong programs in cardiovascular, cancer, infectious disease, and nanomedicine; researchers qualify through publications in high-impact clinical journals, NIH funding as PI, and clinical society recognition; the Weill Cornell affiliation strengthens the distinguished-organization case.
UTHealth Houston & Texas Children's Hospital
UTHealth (schools of public health, medicine, dentistry, and nursing) and Texas Children's Hospital (the largest pediatric hospital in the US) both sponsor EB-1B for permanent faculty and senior researchers; strong programs in public health, pediatrics, and clinical research; publications in JAMA Pediatrics, Pediatrics, and the American Journal of Public Health form the scholarly-articles base.
Rice University & University of Houston
Both sponsor EB-1B for ladder-rank faculty; Rice's nanoscience, bioengineering, and data science programs and UH's engineering, pharmacy, and computing programs generate outstanding-researcher records; the hiring department initiates the sponsorship request and the campus international office coordinates with counsel.
Energy R&D employers (private-employer route)
Large energy companies with qualifying R&D departments — Shell Technology Center, ExxonMobil Research, Aramco Research Center, and Baker Hughes R&D — can sponsor EB-1B under the three-researcher / documented-accomplishments route; principal and senior research scientists with strong publication and patent records qualify, though many prefer the employer-independent EB-1A path.
Eligibility criteria
EB-1B criteria for Houston researchers.
EB-1B requires at least two of six criteria, plus a permanent job offer and at least three years of experience in the field. The criteria are distinct from — and generally lower-threshold than — EB-1A criteria. Houston TMC researchers typically satisfy three or four.
CRITERION 01
Prizes or awards for excellence
ASCO Young Investigator Award, NCI Outstanding Investigator Award, American Heart Association Early Career Award, ACS awards, AACR recognition; Welch Foundation Award; SPE awards for energy researchers; AIAA awards for aerospace researchers.
CRITERION 02
Membership in associations requiring outstanding achievement
American Society for Clinical Investigation, Association of American Physicians; AAAS Fellow; elected fellowship in AHA, AACR, ACR, or ASCI; editorial board membership at major journals requiring demonstrated expertise in the subspecialty.
CRITERION 03
Published material in major media
Coverage in STAT News, Cancer Therapy Advisor, The Scientist, or Nature/Science news features about the researcher's work; profiles in Houston Chronicle science section or Houston Business Journal; institutional press releases picked up by national trade media.
CRITERION 04
Judging the work of others
NIH or NCI study section service (ad hoc or standing); grant review for cancer foundations; editorial board and manuscript peer review for JCO, Nature Medicine, NEJM, Cancer Cell; ASCO or AACR abstract review; award selection committees for oncology or biomedical societies.
CRITERION 05
Original scientific or scholarly contributions
Research cited in NCCN cancer treatment guidelines or AHA/ACC cardiovascular guidelines; discovery of a biomarker or molecular target validated by multiple independent groups; methodology adopted by other labs, documented through citation analysis. Expert declarations describe the contribution's significance.
CRITERION 06
Authorship of scholarly articles
Publications in high-impact peer-reviewed journals — JCO, NEJM, Nature Medicine, Cancer Cell, Nature Genetics, JAMA, Lancet — with citation counts consistent with outstanding standing in the specific research subspecialty.
Houston EB-1B profiles
What qualifying records look like here.
Representative profiles from Houston EB-1B petitions. Identifying details have been generalized.
Assistant Professor
MD Anderson — Department of Thoracic/Head and Neck Medical Oncology
Targeted therapy resistance mechanisms in EGFR-mutant lung cancer
18 publications (senior-author in Cancer Cell, Journal of Thoracic Oncology)
NCI K08 and CPRIT Early Investigator Award
2 NCI study section ad hoc reviews
Invited speaker at ASCO and IASLC Lung Cancer Congresses
MD Anderson sponsored EB-1B through the tenure-track Assistant Professor appointment. The K08 satisfied prizes; study section service satisfied judging; the publication record satisfied scholarly articles. Expert letters from thoracic oncology faculty outside MD Anderson described the researcher's standing in the EGFR resistance subspecialty.
Assistant Professor
Baylor College of Medicine — Department of Molecular and Human Genetics
Copy number variation and genomic structural rearrangements in neurodevelopmental disorders
21 publications; 2,200 citations; senior-author papers in Nature Genetics and AJHG
NIH R01 as PI
American Society of Human Genetics Merit Award
Editorial board, Genome Medicine
Baylor sponsored EB-1B; the permanent faculty appointment served as the job offer. Editorial board membership satisfied judging; ASHG award satisfied prizes; the publication and citation record satisfied scholarly articles. Original contributions were anchored to a CNV discovery adopted by clinical diagnostic labs nationwide.
Senior Research Scientist
Energy company research center — Houston
Subsurface characterization and geomechanical modeling for geologic carbon storage
11 peer-reviewed publications in SPE Journal and International Journal of Greenhouse Gas Control
PI on DOE-funded carbon storage feasibility study
SPE technical committee reviewer
Invited presenter at the SPE Carbon Storage Conference
The energy company sponsored EB-1B under the private-employer route, documenting its R&D department's three-researcher minimum and accomplishments in geomechanics. Original contributions (geomechanical modeling methods cited in carbon storage feasibility studies) and scholarly articles were the lead criteria; DOE funding supported the distinguished-organization argument.
Choosing between pathways
EB-1B vs. EB-1A for Houston researchers — which path first?
EB-1B and EB-1A are complementary green card paths that are most powerful when pursued simultaneously. EB-1B is employer-sponsored — requires a permanent job offer. EB-1A is self-petitioned — requires no employer at all. Both are EB-1 preference category petitions. For Houston TMC researchers at MD Anderson, Baylor, or Houston Methodist, the most common strategy is to have the institution sponsor EB-1B while the researcher simultaneously self-petitions EB-1A. Two approved I-140s provide maximum flexibility, and the EB-1A follows the researcher if they move institutions or leave the TMC entirely.
For Indian and Chinese nationals, this parallel strategy is especially important: filing both I-140s as early as the record allows locks in the earliest possible priority date in the EB-1 category. If EB-1B is denied, EB-1A proceeds independently. For researchers early enough in their careers that EB-1A is not yet achievable, EB-1B is the right first step — with NIW filed simultaneously to establish an early priority date in EB-2 as a backup. Consult the Visa Bulletin for current cutoff dates.
FAQ
Houston EB-1B questions.
MD Anderson has an established immigration office and sponsors EB-1B for permanent faculty appointments at the assistant professor level and above, as well as for comparable permanent research appointments. The sponsorship process flows from the hiring department through MD Anderson's International Faculty and Staff Services office, which coordinates the I-140 filing with outside immigration counsel. The researcher (through counsel) assembles the evidence package: publications, citation analysis, expert letters, peer review records, and awards. MD Anderson's #1 US News ranking is a significant asset — USCIS recognizes MD Anderson as a distinguished research organization in oncology, and faculty appointments there are well-documented evidence of outstanding standing in the field.
EB-1B requires a permanent job offer. A postdoctoral fellowship at MD Anderson or Baylor is not a permanent appointment, and the institution cannot sponsor EB-1B for a postdoc. The EB-1B path opens when the institution offers a permanent faculty appointment (Assistant Professor, Instructor, or equivalent) or a comparable indefinite research-track position. Before that transition, the right instruments are NIW self-petition (to establish an early priority date) or O-1A (for work authorization). A NIW priority date established during the postdoc can remain the controlling date after the EB-1B I-140 is approved, so filing NIW early and EB-1B later is a common combined strategy in the TMC.
Federal agencies, including NASA, generally cannot directly sponsor EB-1B for civil service employees. However, NASA JSC contractors and researchers employed by universities or private organizations that have qualifying research departments may be sponsored by those employers. Additionally, a Rice or UH professor working on a joint NASA program can receive EB-1B sponsorship from the university. Researchers on civil service appointments who are not eligible for EB-1B through a contractor or university arrangement typically use NIW self-petition or EB-1A self-petition, neither of which requires employer sponsorship.
EB-1B requires recognition as outstanding in the specific academic field — lower than EB-1A's extraordinary ability (the very top of the field globally) but higher than NIW's well-positioned standard. For TMC researchers, the typical EB-1B profile: a strong publication record in JCO, Nature Medicine, Cancer Cell, NEJM, or equivalent high-impact journals in the subspecialty; service on NIH or NCI study sections or editorial boards; a research award from a medical or scientific society; and recognition by peers in expert letters that specifically describe the researcher's standing relative to others in the subspecialty. EB-1B also requires at least three years of experience in the field — doctoral and postdoctoral research generally counts.
Where the employer is willing to sponsor and the record supports it, filing both is the strongest strategy. EB-1B (employer-sponsored) and EB-1A (self-petitioned) are both EB-1 preference categories and both avoid PERM. Filing both produces two independent I-140s: if one is denied or the researcher changes institutions, the other survives. For TMC researchers at MD Anderson or Baylor, the common pattern is to have the institution sponsor EB-1B while the researcher simultaneously self-petitions EB-1A — the EB-1A is employer-independent, so it follows the researcher if they move to another institution or leave Houston entirely. For Indian and Chinese nationals facing the EB-1 backlog, filing both as early as the record allows locks in the earliest possible priority date.
